• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[两性霉素B加入胃肠外脂质乳剂。混合物的药剂稳定性。初步结果]

[Amphotericin B into parenteral lipid emulsions. Galenic stability of mixtures. Preliminary results].

作者信息

Blancard A, Monges P, Lacarelle B, Denis J P, Bongrand M C, Ragon C H, Gouin F

机构信息

Service de Santé Publique Faculté de Médecine, Marseille, France.

出版信息

Pathol Biol (Paris). 1996 May;44(5):384-8.

PMID:8758481
Abstract

The amphotericin B in glucose solution is the reference's treatment of the major systemic mycoses. Because of its bad tolerance, certain authors put forward others vehicules such as fat emulsions. The aim of our work has been to study the physico-chemical stability of two regeneration's methods; P1: direct regeneration. P2: regeneration of 50mg of Fungizone in 5 ml of glucose serum and laced with 45 ml of Ivelip 20% versus PR: 50 mg of Fungizone in 50 ml of glucose serum. Our results seem to show that the P1 is totally incompatible with a parenteral administration, because 23% of the granulometric population has a diameter superior to 5 microns. The solution P2 seems better even if the pH is different from PR and a light depot comes after reconstitution.

摘要

葡萄糖溶液中的两性霉素B是治疗主要全身性真菌病的参考药物。由于其耐受性差,一些作者提出了其他载体,如脂肪乳剂。我们工作的目的是研究两种复溶方法的物理化学稳定性;P1:直接复溶。P2:将50mg两性霉素B在5ml葡萄糖溶液中复溶,再加入45ml 20%的依维莫司乳剂,与PR对比:50mg两性霉素B在50ml葡萄糖溶液中复溶。我们的结果似乎表明,P1完全不适合肠胃外给药,因为23%的颗粒群体直径大于5微米。溶液P2似乎更好,即使其pH值与PR不同,复溶后会出现轻微的药物沉积。

相似文献

1
[Amphotericin B into parenteral lipid emulsions. Galenic stability of mixtures. Preliminary results].[两性霉素B加入胃肠外脂质乳剂。混合物的药剂稳定性。初步结果]
Pathol Biol (Paris). 1996 May;44(5):384-8.
2
[Use of amphotericin B in lipid emulsions: does it prevent its toxicity in critically ill patients?].
Rev Med Chil. 2000 Oct;128(10):1101-7.
3
Amphotericin B infused in 20% lipid emulsion.
J Intraven Nurs. 1996 May-Jun;19(3):123-5.
4
Amphotericin B formulated in a lipid emulsion.
Ann Pharmacother. 1996 Apr;30(4):409-12. doi: 10.1177/106002809603000417.
5
Amphotericin B lipid preparations: what are the differences?两性霉素B脂质制剂:有哪些差异?
Clin Microbiol Infect. 2008 May;14 Suppl 4:25-36. doi: 10.1111/j.1469-0691.2008.01979.x.
6
Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability.脂质体两性霉素B滴眼液治疗真菌性角膜炎:物理化学性质及制剂稳定性
Int J Pharm. 2007 Nov 1;344(1-2):150-3. doi: 10.1016/j.ijpharm.2007.04.028. Epub 2007 May 6.
7
Plasma protein adsorption patterns on surfaces of Amphotericin B-containing fat emulsions.两性霉素B脂肪乳剂表面的血浆蛋白吸附模式。
Int J Pharm. 2003 Mar 18;254(1):3-5. doi: 10.1016/s0378-5173(02)00667-1.
8
Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis.葡萄糖与脂肪乳剂用于制备两性霉素以治疗HIV感染合并念珠菌病患者的试验。
BMJ. 1992 Oct 17;305(6859):921-5. doi: 10.1136/bmj.305.6859.921.
9
[Amphotericin B. Lipid complex versus liposomes. Which, why, when?].[两性霉素B。脂质复合物与脂质体。哪一种、为何、何时使用?]
Enferm Infecc Microbiol Clin. 1997 Jan;15(1):1-3.
10
Stability of amphotericin B 0.05 and 0.5 mg/mL in 20% fat emulsion.两性霉素B在20%脂肪乳剂中0.05和0.5毫克/毫升浓度的稳定性
Am J Health Syst Pharm. 1997 Mar 15;54(6):683-6. doi: 10.1093/ajhp/54.6.683.